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Background: Therapeutic mammaplasty (TM) is a standard oncoplastic technique utilising aesthetic 
breast reduction principles to facilitate tumour resection and breast reshaping. Simultaneous contralateral 
mammaplasties are often performed to maintain symmetry. BCCT.core software, which principally assesses 
breast symmetry, has been previously employed for evaluating cosmetic results after standard breast 
conservation therapy and latterly TMs for upper pole tumours. The purpose of this study was to validate this 
novel tool for TMs in all breast zones. 
Methods: Standardised photographs of 20 consecutive patients who underwent TM were evaluated for 
symmetry using BCCT.core versus a plastic surgical panel completing a visual analogue scale. Results were 
rated as (excellent/good/fair/poor). Outcomes between the two methods were compared. 
Results: Twenty patients aged 37 to 63 years with a median 36G bra size had 22 TMs (18 unilateral, 2 
bilateral). Indications were invasive breast cancer (87%) and ductal carcinoma in situ (DCIS) (13%). The 
median (range) tumour size was 22.5 mm (6–90 mm) with a resection weight of 245.8 g (16–1,079 g). 
Primary nipple pedicles were superomedial (63%), inferior (21%) and superolateral (16%). Five patients 
required a secondary glandular pedicle for volume redistribution to maintain breast shape. The BCCT.core 
software vs. panel symmetry assessments were 37% vs. 39% (excellent), 63% vs. 50% (good) and 0% vs. 
11% (fair). Wilcoxon matched-pairs sign rank tests and Spearman rank correlations found the pairings to be 
statistically significant (P<0.05).
Conclusions: Despite small patient numbers, BCCT.core gave comparable findings with the panel and is 
thus useful for objectively assessing cosmesis of TMs in all breast zones.
Keywords: Therapeutic mammaplasty (TM); breast reduction; Wise pattern; wide local excision (WLE); 
contralateral balancing surgery; breast symmetry; BCCT.core; oncoplastic surgery
Submitted Aug 15, 2018. Accepted for publication Sep 12, 2018.
doi: 10.21037/gs.2018.09.06 
View this article at: http://dx.doi.org/10.21037/gs.2018.09.06 
225
219Gland Surgery, Vol 8, No 3 June 2019
© Gland Surgery. All rights reserved.   Gland Surg 2019;8(3):218-225 | http://dx.doi.org/10.21037/gs.2018.09.06 
Introduction
Therapeutic mammaplasty (TM) is one of the most versatile 
techniques in oncoplastic breast surgery (OBS). Breast 
cancer resection is completed followed by reconstitution 
of breast shape employing breast reduction or mastopexy 
techniques (1). TM is often performed with simultaneous 
contralateral balancing surgery in order to maintain 
symmetry. These immediate symmetrising procedures are 
advantageous in improving overall patient satisfaction (2), 
which has been demonstrated to improve the patient’s 
quality of life (3). An evaluation of outcomes and 
refinements in the technique of TM over 20 years [1994–
2015] by the Emory University group comparing early and 
more recent cases showed that the technique is effective 
and increases patient satisfaction (4). A key advantage of 
TM is that it achieves significantly lower positive margin 
rates due to the wider excision and can be more successful 
in obtaining oncological clearance with less re-excisions 
compared with standard breast conserving surgery (BCS) (5). 
Its indications include anticipated poor cosmetic outcome 
with standard BCS, tumours in large and often ptotic 
breasts, as an alternative to mastectomy and the prevention 
of lymphedema, fibrosis and chronic pain sometimes 
associated with irradiating large breasts (6). 
Although TM is well established there is a paucity 
of literature pertaining to the objective analysis of its 
aesthetic outcomes (6-8). Hence it was the aim of this 
study to compare objective and subjective evaluations of 
the cosmetic outcomes of patients who had undergone TM 
in the Cambridge Breast Unit (CBU). This was assessed 
objectively using the Breast Cancer Conservation Treatment 
cosmetic results software (BCCT.core) and subjectively 
using a panel of surgeons. 
The BCCT.core is a validated evaluation tool for 
analysing cosmetic outcomes following standard BCS 
(8-12). It assesses breast asymmetry, skin colour difference 
and scar visibility (13). The software has previously been 
applied to evaluate outcomes following standard wide 
local excision (WLE) (10,14), and very recently following 
TM for upper pole breast tumours (15). However, until 
now it has not been used to assess tumours in all locations 
within the breast. We aimed to establish its use for such 
tumours by comparing results with subjectively obtained 
data using pre- and post-operative photos. Subjective 
data were obtained from ratings of a plastic surgical 
panel using a Visual Analogue Scale (VAS) to assess the 
photographs. 
Methods
Twenty patients were identified that had had therapeutic 
mammaplast ies  performed joint ly  with the same 
oncologic breast surgeon performing the WLEs and any 
necessary axillary surgery. All resections were assessed 
by intraoperative X-ray and additional tissue taken as 
indicated. Prior signed informed consent was obtained 
from all the patients for evaluation of their anonymised 
photographs. Electronic and paper clinical records were 
reviewed to identify relevant clinico-pathological features 
namely patient demographics, tumour and treatment 
characteristics. These included pre-operative investigations, 
surgery techniques & pedicles used, tumour location & 
size, resection weights, excision margins and post-operative 
radiotherapy (RT) received. 
Standardised photographs of 20 patients both pre-
operatively and at a median of 7 months post-operatively 
were taken by a dedicated medical photographer. All 
patients were photographed in frontal, both lateral and both 
oblique positions with their arms behind their backs using 
the same source of lighting and distance from camera in 
order to avoid any differences in skin colour and angle. For 
breast symmetry assessments, only anterior-posterior (AP) 
views were used.
Objective assessment required pre- and post-operative 
frontal-view photographs to be loaded into the BCCT.
core software program with the following landmarks being 
digitally marked: nipples, suprasternal notch and the most 
medial and lateral points of the breasts. The software then 
automatically adjusted the outline of the breast contour 
and generated the final cosmetic result, classified as 1 of 4 
categories, i.e., excellent, good, fair, poor (Figure 1), based 
on the Harvard Scale introduced by Harris in 1979 (16). 
The results for both the pre and post-operative photographs 
were then compared. 
Subjective analysis was conducted by anonymised 
photographs being presented to the panel which consisted 
of 16 members. They were shown both pre- and post-
operative frontal views of the 20 patients. Each member 
of the panel then scored the breasts using size and shape 
symmetry criteria on the 10-point VAS. The data were 
compiled on an excel spreadsheet and the mean score 
for each patient calculated. In order for results to be 
comparable to the objective assessment, the score was then 
re-categorised (0 to <2.5, 2.5 to <5, 5 to <7.5, 7.5–10) to 
correspond to the BCCT.core scoring (poor, fair, good, 
excellent).
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Results 
General
A total of 20 patients who underwent 22 TMs were 
reviewed. Their mean age was 51.5 years (range, 37– 
63 years). Ninety-four percent of patients received adjuvant 
RT. The indications for the TM were invasive breast cancer 
(87%) and ductal carcinoma in situ (DCIS) (13%). Tumour 
size ranged from 6 to 90 mm (median 22.5 mm), the median 
resection weight was 245.8 g (range, 16–1,079 g) and the 
median closest margin was 8 mm. The majority of tumours 
were invasive carcinoma of no special type (NST) (56.5%), 
followed by DCIS (13%), mixed NST + DCIS (17.4%), 
mixed lobular + NST (8.7%) and lobular (4.4%). 
Most tumours were located in zone 6 of the breast (39%) 
followed equally by zone 4 and 7 (18%). Primary nipple 
pedicles for the lumpectomy defects were; superomedial 
(63%), inferior (21%) and superolateral (16%). Five 
patients had a secondary pedicle to facilitate parenchymal 
redistribution to optimise breast reshaping and maintenance 
of a satisfactory contour. Three patients had a Grisotti style 
rotation-advancement flap to recreate an areola.
Axillary surgery concurrently done was performed 
through the breast incision in 13/18 cases [7 clearances, 11 
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Figure 1 A 49-year-old female with E-cup breasts and BMI of 25.8 kg/m2, shown preoperatively (A,C,E) and 21 months post-op (B,D,F) 
following Wise pattern therapeutic mammaplasties using a superolateral pedicle for a tumour in the right lower outer quadrant and as a 
balancing procedure on the left. This patient was rated as “excellent” pre-op (A) and post-op (B) by BCCT.core software. 
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sentinel lymph node biopsies (SLNB)]. The remaining four 
cases had upfront SLNB prior to neoadjuvant chemotherapy 
or completion clearance for a positive SLNB.
The pedicle technique used for simultaneous contralateral 
balancing mammaplasty was the same as for the index breast 
in 75%. Contralateral breast tissue resection weights ranged 
from 59 to 1,366 g (median 610 g) and were all benign. No 
revision operations were requested nor required in the index 
breasts and no further balancing surgery was performed on 
the opposite breast. 
One out of the 20 patients had a complication (5% 
complication rate) consisting of T-junction wound 
breakdown accompanied by fat necrosis. She however did 
not require adjustment procedures. One patient did not 
attend for post-operative photographs so her images could 
not be analyzed on BCCT.core or by the panel.
Objective assessment by BCCT.core 
Thirty-seven percent (n=7) of the patients achieved 
excellent scoring post-operatively (Figures 1,2) and 63% 
(n=12) achieved good symmetry (Figure 3). Post-operative 
breast symmetry improved from good to excellent in 37% 
of breasts (n=7) (Figure 2), whilst for 16% (n=3) of patients 
the symmetry reduced from excellent to good (Figure 3). 
In the remaining patients, the score was maintained as 
excellent or good.
Subjective assessment by panel 
When frontal-view post-operative breast symmetry was 
assessed by the panel, it was rated as excellent in 32% (n=6) 
of patients, good in 58% (n=11) and fair in 10% (n=2). 
Twenty-one percent of these scores were an improvement 
on the pre-operative appearances, 69% of scores were 
maintained, and 10% were reduced. In the oblique photos, 
the 15% (n=3) were classed as excellent and 85% (n=16) as 
good; with 15% being an improved score, 5% a reduction 
and the rest maintaining their scores. 
Oncological outcomes
Two patients had positive resection margins (10% re-
excision rate). One had extensive invasive lobular cancer, 
grossly underestimated on preoperative MRI and went on 
to a completion mastectomy and deep inferior epigastric 
artery perforator (DIEP) flap immediate reconstruction. 
The other was for DCIS and she underwent mastectomy 
and implant-based reconstruction. There have been no 
recurrences in any of the 20 patients to date.
Comparison of BCCT.core to panel assessment
Analysis using the Wilcoxon matched-pairs signed rank 
sum test found that the comparisons between objective 
and subjective ratings found no difference between them 
on the pre-operative (P=0.70) or post-operative (P=0.30) 
appearances. Similarly, when the two groups were combined 
(pre-op + post-op scores) there was no significant difference 
between the objective and subjective assessments signifying 
a high concordance rate between them. 
To assess similarity, Spearman rank order tests found 
that the objective and subjective ratings for the pre-
operative photos were significantly similar (P=0.003, 
rs =0.57). It also found the two ratings for the post-
operative photos to be significantly similar (P=0.02, 
rs =0.45). When grouping together all photos, assessments 
of pairing effectiveness found that subjective and objective 
scoring were significantly similar (P=0.0004, correlation 
coefficient r=0.50) (Figure 4). 
Discussion
TM has evolved to become a versatile tool to facilitate 
BCS while preserving the breast form. Oncoplastic BCS 
where appropriate is preferable to mastectomy as it has 
been shown to be as oncologically safe as mastectomy when 
combined with RT, but leaves the patient with a sensate 
breast. 
The Wise pattern was the most common skin excision 
technique because of its versatility in allowing use of 
different dermoglandular pedicles (17). Additionally, for 
large breasts, as were most of the breasts in our study 
(median cup size: 36G), it facilitates generous tissue and 
skin excision resulting in a better aesthetic outcome (18). 
TM requires that the surgeon is well versed in all breast 
reduction techniques. This was demonstrated in the 
variation of our series where superomedial, superior, 
superolateral, inferior and central pedicles were used, as 
were different combinations with non-nipple bearing (such 
as the Grisotti flap), nipple-bearing or nipple-transposing 
pedicles. 
TM is effective in maintaining breast cosmesis and often 
even enhancing it. This has been demonstrated by objective 
assessment, using BCCT.core software which aims to 
standardise aesthetic evaluation after BCS. When compared 
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to subjective evaluation using a 10-point VAS there was a 
significant concordance of the results in paired matching 
statistical tests. The panel and BCCT.core assessments 
rated the aesthetic outcomes as good or excellent in the 
majority of cases, reflecting the TMs effectiveness for breast 
cosmesis in general and breast symmetry in particular. 
Interestingly, the panel was more critical of the outcomes 
as they rated two patients (1 in 10) as only fair. However, 
when comparing differences between pre- and post-
operative photos, both objective and subjective scoring 
systems showed congruent results, with similar values for 
improving, maintaining and reducing cosmesis. BCCT.core 
was therefore very useful for objectively assessing cosmesis 
and, despite the small patient numbers, gave comparable 
findings with the panel, thus suggesting the validity of 
BCCT.core for all breast zones. These positive aesthetic 
results would have been achieved through joint plastic 
and oncological breast surgical meticulous pre-operative 
A B C
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G
Figure 2 A 52-year-old female with a BMI of 40 kg/m2 and 48G cup breasts, shown preoperatively (A,C,E) and 18 months post-op (B,D,F) 
following Wise pattern therapeutic mammaplasty with a superomedial pedicle on the left and right-sided superomedial balancing reduction. 
This patient was rated as “good” pre-op (A) and “excellent” post-op (B) by BCCT.core software. Dotted markings in pre-op image (G) 
outline the 75-mm unifocal tumour in the left upper outer quadrant. The Wise pattern, as seen by solid-line markings (G), was skewed 
laterally in order to adequately include the lateral tumour in the excision and reduce the length of its lateral flap thereby improving its 
vascularity. 
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Figure 3 A 52-year-old female with 38G cup breasts and BMI of 36, shown preoperatively (A,C,E,G) and 21 months post-op (B,D,F,H) 
following Wise pattern therapeutic mammaplasty using a superomedial pedicle for a tumour on the left lateral side, and right-sided 
balancing reduction with a superomedial pedicle. This patient was rated as “excellent” pre-op (A) and “good” post-op (B) by BCCT.core 
software. 
A B
C D
E F
G H
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planning and marking of skin paddles to guide excisions and 
joint intraoperative execution of the surgical plans.
Our series has shown that it is possible to remove 
large tumours in large breasts with good margins using 
oncoplastic techniques. These cases would have traditionally 
been treated by mastectomy. Studies have shown that 
patient-reported outcome measures (PROMs) are better in 
BCS compared to mastectomy (19,20). In addition in those 
patients with large ptotic breasts breast reduction has been 
associated with high patient satisfaction and therefore it is 
understandable that both the panel and BCCT software 
have in some cases demonstrated an improvement in 
cosmesis post-surgery (21). 
A limitation of our study was the relatively small sample 
size, but despite this, satisfactory results were obtained, 
both subjectively and objectively. The BCCT.core software, 
whilst being an objective, innovative and reproducible tool, 
uses only frontal-view 2D photographs. This limits its 
ability to evaluate the depth, projection and breast volume 
which would require 3D visualisation. However, since the 
BCCT.core bases its results on skin colour and scar visibility 
in addition to breast symmetry, it may combine sufficient 
information to give accurate applicable results (8).
TM is effective in achieving good oncological and 
cosmetic outcomes in both small and large resections during 
BCS for cancer. Achieving clear margins with minimal 
morbidity in selected breast cancer patients ultimately 
results in very favourable overall clinical and aesthetic 
results. The BCCT.core software is a useful objective tool 
in the simple and accurate analysis of post-operative results 
in patients undergoing TM. Our study validates that its use 
was comparable to a subjective analysis using the VAS tool 
by a team of 16 specialty doctors. 
Conclusions
We demonstrated the feasibility of BCCT.core software use 
in TMs for cancers in all breast locations having compared 
this with a plastic surgical panel. Notwithstanding the small 
patient numbers, the software results were comparable with 
findings of the panel. This suggests validity of BCCT.core 
for all breast zones.
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